TASLY PHARMACEUTICAL GROUP CO LTD revenue breakdown overview

TASLY PHARMACEUTICAL GROUP CO LTD revenue for the last year amounted to 8.50 B CNY, the most of which — 6.02 B CNY — came from its highest performing source at the moment, Traditional Chinese Medicine, the year earlier bringing 5.97 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought TASLY PHARMACEUTICAL GROUP CO LTD 8.46 B CNY, and the year before that — 8.64 B CNY.